Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC Abemaciclib metabolite M20 | 2138499-06-4 | 98.2% | 100 MG
SDP

Catalog No. 5000340021
Encompass_Preferred

Abemaciclib metabolite M20 (LSN3106726) is the active metabolite of Abemaciclib and a selective CDK4/6 inhibitor for the treatment of cancer. It induces senescence in breast cancer cells at concentrations of 200 nM and 500 nM over 6-8 days.

  • Induces senescence in breast cancer cells.
  • Inhibits the growth and cell cycle progression of non-small cell lung cancer (NSCLC) cells, colorectal cancer (CRC) cells, and breast cancer cells.
  • IC50 value for CDK4 and CDK6 is in the range of 1-3 nM.

Catalog No. 50-003-40021 Supplier Medchemexpress LLC Supplier No. HY129336100MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

Abemaciclib metabolite M20 (LSN3106726) is the active metabolite of Abemaciclib and a selective CDK4/6 inhibitor for the treatment of cancer. It induces senescence in breast cancer cells at concentrations of 200 nM and 500 nM over 6-8 days.

  • Induces senescence in breast cancer cells.
  • Inhibits the growth and cell cycle progression of non-small cell lung cancer (NSCLC) cells, colorectal cancer (CRC) cells, and breast cancer cells.
  • IC50 value for CDK4 and CDK6 is in the range of 1-3 nM.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.